Kaiser Permanente

Category

The COVAS Tool: Kaiser Permanente Southern California Develops Tool to Predict Outcomes for COVID-19 in Emergency Dept. Setting

Kaiser Permanente Southern California Department of Research & Evaluation has developed a COVID-19 risk assessment factoring in a number of patient variables enabling a critical poor outcome without the need for any laboratory or diagnostic testing as reported in...

Kaiser Permanente Research Reveals Depressed Pregnant Women Eating Poorly Putting Themselves and Future Children at Risk

A Kaiser Permanente Division of Research study revealed that pregnant women with depression are far more likely to eat poor diets, with higher intake of empty calories, that may have adverse, lasting consequences on a next generation of children. Published in the...

Kaiser Permanente Participating in AbbVie-Sponsored International Clinical Trial Targeting Ovarian Cancer with PARP Inhibitor Called Veliparib

Kaiser Permanente Research radio recently interviewed Dr. Michael A Bookman, an oncologist and investigator with Kaiser, discussing his participation in an international clinical trial sponsored by AbbVie, focusing on a PARP inhibitor called Veliparib to treat ovarian...

Pin It on Pinterest